首页> 外文期刊>Case Reports & Clinical Practice Review >A Case of Left Renal Vein Ligation in a Patient with Solitary Left Kidney Undergoing Liver Transplantation to Control Splenorenal Shunt and Improve Portal Venous Flow
【24h】

A Case of Left Renal Vein Ligation in a Patient with Solitary Left Kidney Undergoing Liver Transplantation to Control Splenorenal Shunt and Improve Portal Venous Flow

机译:左肾独立结扎行肝移植以控制脾肾分流并改善门静脉血流的一例

获取原文
           

摘要

Objective: Rare co-existance of disease or pathologyBackground: Adequate portal venous flow is required for successful liver transplantation. Reduced venous flow and blood flow ‘steal’ by collateral vessels are a concern, and when there is a prominent splenorenal shunt present, liga- tion of the left renal vein has been recommended to improve portal venous blood flow. Case Report: A 51-year-old man who had undergone right nephrectomy in childhood required liver transplantation for liver cirrhosis and hepatocellular carcinoma due to hepatitis C virus (HCV) infection. The patient had no other co- morbidity and no history of hepatorenal syndrome. At transplantation surgery, portal venous flow was poor and did not improve with ligation of shunt veins, but ligation of the left renal vein improved portal venous flow. On the first and fifth postoperative days, the patient was treated with basiliximab, a chimeric monoclonal anti- body to the IL-2 receptor, and methylprednisolone. The calcineurin inhibitor, tacrolimus, was introduced on the fifth postoperative day. On the sixteenth postoperative day, renal color Doppler ultrasound showed normal left renal parenchyma; hepatic Doppler ultrasound showed good portal vein flow and preserved hepatic parenchy- ma in the liver transplant.Conclusions: This case report has shown that in a patient with a single left kidney, left renal vein ligation is feasible and safe in a patient with no other risk factors for renal impairment following liver transplantation. Modification of post- operative immunosuppression to avoid calcineurin inhibitors in the very early postoperative phase may be im- portant in promoting good recovery of renal function and to avoid the need for postoperative renal dialysis.
机译:目的:罕见的疾病或病理并存背景:成功的肝移植需要足够的门静脉血流。减少侧支血管引起的静脉血流和血流“窃取”是一个问题,当存在明显的脾肾分流时,建议左肾静脉结扎以改善门静脉血流。病例报告:一名51岁的男性在儿童时期接受了右肾切除术,由于丙型肝炎病毒(HCV)感染而需要肝移植治疗肝硬化和肝细胞癌。该患者没有其他合并症,也没有肝肾综合征的病史。移植手术时,门静脉血流较差,结扎分流静脉并没有改善,但左肾静脉的结扎改善了门静脉血流。在术后的第一天和第五天,用巴立昔单抗(一种针对IL-2受体的嵌合单克隆抗体)和甲基泼尼松龙对患者进行治疗。术后第五天引入钙调神经磷酸酶抑制剂他克莫司。术后第十六天,肾脏彩色多普勒超声检查显示左肾实质正常。肝多普勒超声显示肝移植中良好的门静脉血流并保留了肝实质。结论:本病例报告显示,对于单发左肾的患者,左肾静脉结扎术对其他无肾移植的患者是可行且安全的肝移植后肾功能损害的危险因素。修改术后免疫抑制以避免钙调神经磷酸酶抑制剂在术后早期就可能对促进肾功能良好恢复和避免术后肾脏透析很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号